Lung Cancer: A Wily Genetic Opponent

Cell
Peggy P Hsu, Alice T Shaw

Abstract

In two companion reports, the TRACERx consortium investigates tumor heterogeneity and evolution in early-stage non-small cell lung cancer. The studies highlight the prognostic value of copy-number heterogeneity assessment in tumor biopsies and circulating tumor DNA detection in plasma and suggest that tracking the evolution of lung cancers might aid clinical practice.

Citations

Sep 21, 2018·Expert Opinion on Drug Delivery·Mariana MagalhãesFrancisco Veiga
Oct 28, 2019·Future Oncology·Darrell D Davidson, Liang Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.